Search research articles
Contact Us
Filters
Showing results (11-20 of 112) with videos related to
Page
of 12
Sort By:
BJU International
|
July 5, 2011
Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry
Nivedita Dhar, John F Ward, Michael L Cher, et al.
Urologic Oncology
|
December 12, 2002
Presence of circulating prostate cancer cells in African American males adversely affects survival
Fernando J Bianco, Isaac J Powell, Michael L Cher, et al.
BMJ Open
|
February 22, 2022
Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol
Jinping Xu, Michael Goodman, James Janisse, et al.
Journal of Robotic Surgery
|
May 5, 2017
Prospective assessment of positioning-related pain in robotic urologic surgery
Kevin B Ginsburg, Kelsey Pape, Chase Heilbronn, et al.
Current Problems in Cancer
|
May 1, 2021
Association of lymph node yield with overall survival in patients with pathologically node negative prostate cancer
Kevin B Ginsburg, Mark F Pressprich, Hallie A Wurst, et al.
Urologic Oncology
|
September 11, 2007
Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis
R Daniel Bonfil, Sreenivasa Chinni, Rafael Fridman, et al.
Open Forum Infectious Diseases
|
May 9, 2017
Infection-Related Hospital Admissions After Prostate Biopsy in United States Men
Richard Evans, Aram Loeb, Keith S Kaye, et al.
The Prostate
|
September 1, 2017
Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation
Kevin B Ginsburg, Ahmed Elshafei, Changhong Yu, et al.
Cancer Research
|
May 3, 2006
Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer
Yiwei Li, Omer Kucuk, Maha Hussain, et al.
Clinical & Experimental Metastasis
|
October 4, 2003
Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases
Jeffrey A Nemeth, Michael L Cher, Zhao Zhou, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 112) with videos related to
Sort By:
Page
of 12
BJU International
|
July 5, 2011
Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry
Nivedita Dhar, John F Ward, Michael L Cher, et al.
Urologic Oncology
|
December 12, 2002
Presence of circulating prostate cancer cells in African American males adversely affects survival
Fernando J Bianco, Isaac J Powell, Michael L Cher, et al.
BMJ Open
|
February 22, 2022
Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol
Jinping Xu, Michael Goodman, James Janisse, et al.
Journal of Robotic Surgery
|
May 5, 2017
Prospective assessment of positioning-related pain in robotic urologic surgery
Kevin B Ginsburg, Kelsey Pape, Chase Heilbronn, et al.
Current Problems in Cancer
|
May 1, 2021
Association of lymph node yield with overall survival in patients with pathologically node negative prostate cancer
Kevin B Ginsburg, Mark F Pressprich, Hallie A Wurst, et al.
Urologic Oncology
|
September 11, 2007
Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis
R Daniel Bonfil, Sreenivasa Chinni, Rafael Fridman, et al.
Open Forum Infectious Diseases
|
May 9, 2017
Infection-Related Hospital Admissions After Prostate Biopsy in United States Men
Richard Evans, Aram Loeb, Keith S Kaye, et al.
The Prostate
|
September 1, 2017
Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation
Kevin B Ginsburg, Ahmed Elshafei, Changhong Yu, et al.
Cancer Research
|
May 3, 2006
Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer
Yiwei Li, Omer Kucuk, Maha Hussain, et al.
Clinical & Experimental Metastasis
|
October 4, 2003
Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases
Jeffrey A Nemeth, Michael L Cher, Zhao Zhou, et al.
Page
of 12